Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patients

by Steven Deitelzweig, Allison Keshishian, Amiee Kang, Amol D. Dhamane, Xuemei Luo, Neeraja Balachander, Lisa Rosenblatt, Jack Mardekian, Jenny Jiang, Huseyin Yuce, Gregory Y. H. Lip
Published 2021-03-01

Effectiveness and Safety of Oral Anticoagulants among NVAF Patients with Obesity: Insights from the ARISTOPHANES Study

by Steve Deitelzweig, Allison Keshishian, Amiee Kang, Amol D. Dhamane, Xuemei Luo, Xiaoyan Li, Neeraja Balachander, Lisa Rosenblatt, Jack Mardekian, Xianying Pan, Manuela Di Fusco, Alessandra B. Garcia Reeves, Huseyin Yuce, Gregory Y. H. Lip
Published 2020-05-01

Switching to Another Oral Anticoagulant and Drug Discontinuation Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Different Direct Oral Anticoagulants

by Christine L. Baker JD, MPH, Amol D. Dhamane BPharm, MS, Jigar Rajpura PhD, Jack Mardekian PhD, Oluwaseyi Dina MPH, Cristina Russ MD, PhD, Lisa Rosenblatt MD, MPH, Melissa Lingohr-Smith PhD, Jay Lin PhD, MBA
Published 2019-08-01